Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
KRYS holding history
Krystal Biotech, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −26,746−100.0% | Sold out | Holders |
| Q1 2024 | 26,746 | $4.76M | 0.8% | +1,746+7.0% | Added | Holders |
| Q4 2023 | 25,000 | $3.10M | 0.6% | −32,500−56.5% | Reduced | Holders |
| Q3 2023 | 57,500 | $6.67M | 2.2% | +57,500 | New | Holders |